Riskpilot← Back to searchSign inGet full accessKNAPSTAD APOTEK AS
ASActiveOrg 924812524Spydebergveien 3, 1823 KnapstadRetail sale of pharmaceutical products · NACE 4773Est. 202011 employees
Revenue 2025
NOK 15,2M
-18% vs 2024
EBITDA margin
0.3%
-95% vs 2024
Equity ratio
23.0%
Financial strength
Net profit 2025
NOK -83K
-114% vs 2024
| Revenue | NOK 15,2M | -18% |
| EBITDA | NOK 49K | -95% |
| Net profit | NOK -83K | -114% |
| Total assets | NOK 3,1M | -3% |
| Equity | NOK 717K | -10% |
| Employees | 11 | — |
Legal name
KNAPSTAD APOTEK AS
Org number
924812524
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
20. mars 2020
Share capital
NOK 35 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Eie og drive apotek.
Address
Spydebergveien 3, 1823 Knapstad
Phone
+4769700290
Email
kundeservice@vitusapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 12 187 | 11 357 | 16 460 | 18 480 | 15 177 |
| Staff expenses | −1 661 | −2 254 | −2 769 | −2 555 | −2 609 |
| EBITDA | 1 209 | 688 | 1 057 | 912 | 49 |
| Depreciation & amort. | −120 | −120 | −120 | −135 | −123 |
| EBIT | 1 089 | 568 | 936 | 777 | −74 |
| Net financials | −55 | −53 | −33 | −28 | −21 |
| Profit before tax | 1 035 | 514 | 903 | 749 | −94 |
| Tax | 226 | 113 | 206 | 175 | −12 |
| Net profit | 809 | 401 | 697 | 573 | −83 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 359 | 3 987 | 8 479 | 3 210 | 3 120 |
| Equity | 1 487 | 1 229 | 226 | 799 | 717 |
| Long-term debt | 1 243 | 1 044 | 852 | 440 | 0 |
| Short-term debt | 2 629 | 1 714 | 7 401 | 1 971 | 2 092 |
| Total debt | 3 872 | 2 758 | 8 253 | 2 411 | 2 403 |
EBITDA margin
0.3%
This company
15.8%
Market median
-98% vs market
20212025
Equity ratio
23.0%
This company
38.2%
Market median
-40% vs market
20212025
Return on equity
-11.5%
This company
18.4%
Market median
-163% vs market
20212025
Net profit margin
-0.5%
This company
8.1%
Market median
-106% vs market
20212025
Asset turnover
4.86×
This company
1.12×
Market median
+334% vs market
20212025
Debt / equity
3.35×
This company
0.62×
Market median
-440% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MM Chief Executive Officer | Chief Executive Officer | 2020 |
NA Chief Executive Officer | Chief Executive Officer | 2025 |
ZA Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Deputy Chairman | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 38% | 38% | 2023 | |
| Company | 33% | 33% | 2023 | |
| Individual | 18% | 18% | 2024 | |
| Company | 11% | 11% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KNAPSTAD APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malik Mumtaz Hussain Taqi | Chief Executive Officer | 0 companies |
| Noman Asif | Chief Executive Officer | 0 companies |
| Zaheer Ali | Chief Executive Officer | 0 companies |
| Tariq Ejaz | Chairman | 0 companies |
| Muhammad Sadiq | Board of Directors | 0 companies |
| Muhammad Furqan | Deputy Chairman | 0 companies |